Gert van Houwelingen, MD

Original Contribution

Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score

02/29/2012

Christian W. Hamm , MD, PhD, FESC;

Jurrien M. ten Berg , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Gert van Houwelingen , MD;

Jan-Henk E. Dambrink , MD, PhD;

Pieter R. Stella , MD, PhD;

Jan Paul Ottervanger , MD, PhD;

Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...

Abstract: Aims. The aim of this...

02/29/2012

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Gert van Houwelingen, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products